The new report titled “Global
Hemostats Market by Key Players Analysis (Ethicon US LLC, Pfizer Inc. and
C.R. Bard Inc.), Drivers, Size, Share, Overview, Outlook, Trends and Forecast
Period 2017-2024”, also the Global Hemostats Market is expected to reach USD
4.5 billion by 2024 from USD 2.7 billion in 2016, growing at a CAGR of 6.6% in
the forecast period 2017 to 2024.
The new market report contains data for historic year 2015,
the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Thrombin based hemostats market has the largest market segment in hemostats
market.
The global hemostats
market is highly concentrated market with major key players and local
players to cater the domestic market. Ethicon US LLC dominated the hemostats
market accounting for the highest market share in 2016, followed by Pfizer
Inc., and C.R. Bard Inc. Other players in the market include Baxter, Vascular
Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an
Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch
Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc.,
Hemostasis, LLC, MedTrade Products Limited., Integra LifeSciences Corporation,
Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring,
Mallinckrodt, and Equimedical, B.V. holds a share of 15.3% of the global
hemostats market in 2016.
Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
ETHICON US, LLC
(SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC):
Founded in 1886 and headquartered at New Brunswick, New
Jersey, U.S., Ethicon US, LLC., a subsidiary of Johnson & Johnson Services,
Inc. is engaged in the development and marketing of healthcare products. The
company operates through three business segments- Consumer, Pharmaceutical, and
Medical Devices.
Recent developments:
1. In June,
2017 Ethicon US, LLC received FDA approval for SURGICEL powder absorbable
hemostat. This hemostat powder will help surgeons to have a simple and predictable
adjunctive hemostatic solution to control continuous oozing on broad or raw
surfaces.
2. In
August, 2016 Ethicon US, LLC collaborated with Touch Surgery to improve
patient’s condition through Ethicon surgical products.
Inquiry
before Buying about this Market Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market
Pfizer:
Founded in 1849 and headquartered in New York, U.S., Pfizer
Inc., is engaged in discovering, developing and, manufacturing of healthcare
products. Pfizer operates through two segments: Pfizer Innovative Health (IH)
and Pfizer Essential Health (EH). The IH segment concentrates on creating and
commercializing immunizations and prescriptions that enhance patients' lives,
and in addition products for the end user health care. The EH segment includes legacy brands, branded generics,
generic sterile injectable products, biosimilars and infusion systems,
inadditon to research and development.
C.R BARD:
Founded in 1907 and headquartered at Murray Hill, New
Jersey, USA, C. R. Bard, Inc. is engaged in the development, manufacturing and
marketing of medical technologies. The company operates through four business
segments- vascular, urology, oncology, and surgical specialties.
Recent Developments:
1. In
August, 2013 C. R. Bard, Inc. acquired Medafor, Inc. a leading developer and
supplier of plant based hemostatic agents. This acquisition would enhance the
company's business opportunities.
Table
of Contents:
1.
INTRODUCTION
2.
RESEARCH METHODOLOGY
3.
MARKET LANDSCAPE SUMMARY
4.
PREMIUM INSIGHTS
5.
HEMOSTATS MARKET, BY PRODUCT TYPE
6.
HEMOSTATS MARKET, BY INDICATION
7.
HEMOSTATS MARKET, BY END-USER
8.
HEMOSTATS MARKET, BY GEOGRAPHY
9.
HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
10.
HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND
JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED
MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.18.1. OVERVIEW
10.18.2. SWOT ANALYSIS
10.18.3. PRODUCT PORTFOLIO
10.18.4. REVENUE ANALYSIS
10.18.5. ANALYSTS VIEW
10.19. STRYKER
10.19.1. OVERVIEW
10.19.2. SWOT ANALYSIS
10.19.3. PRODUCT PORTFOLIO
10.19.4. REVENUE ANALYSIS
10.19.5. ANALYSTS VIEW
10.20. HEMOSTASIS, LLC.
10.20.1. OVERVIEW
10.20.2. SWOT ANALYSIS
10.20.3. PRODUCT PORTFOLIO
10.20.4. REVENUE ANALYSIS
10.20.5. ANALYSTS VIEW
10.21. CSL BEHRING
10.21.1. OVERVIEW
10.21.2. SWOT ANALYSIS
10.21.3. PRODUCT PORTFOLIO
10.21.4. REVENUE ANALYSIS
10.21.5. ANALYSTS VIEW
10.22. MALLINCKRODT PLC.
10.22.1. OVERVIEW
10.22.2. SWOT ANALYSIS
10.22.3. PRODUCT PORTFOLIO
10.22.4. REVENUE ANALYSIS
10.22.5. ANALYSTS VIEW
10.23. EQUIMEDICAL, B.V.
10.23.1. OVERVIEW
10.23.2. SWOT ANALYSIS
10.23.3. PRODUCT PORTFOLIO
10.23.4. REVENUE ANALYSIS
10.23.5. ANALYSTS VIEW
If you want to purchase this report kindly
send the email @ Sales@databridgemarketresearch.com
Related
Report
Global
Hernia Repair Devices Market – Industry Trends and Forecast to 2024
Global Hernia Repair Devices Market By
Product Type, End User, Geography (North America, Europe, APAC, South America,
MEA)–Industry Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric Market
research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data Bridge
Market Research
Tel:
+1-888-387-2818
Investor: investors@databridgemarketresearch.com